CAMP
CAMP4 Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.41
−1.78%Margins
Gross margin
77.8%
EBITDA margin
-1735.5%
EBIT margin
-1242.5%
Net margin
-2543.7%
FCF margin
-681.2%
—
Return on equity
-114.8%
Return on assets
-3120.0%
Return on invested capital
0.04x
Asset turnover
-$28.6M
Cash from operations
$1.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026